A new study indicates that survivors of the Holocaust have experienced a small but consistent increase in the risk of developing cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings offer an example of how extreme population-level tragedies can have an impact on health.
Holocaust survivors were exposed to a variety of factors that have been linked with cancer. Siegal Sadetzki, MD, MPH, of the Chaim Sheba Medical Center in Israel, and her colleagues wondered whether the starvation, overcrowding, infectious diseases, and psychological stress that survivors endured might have contributed to the development of cancer in some individuals.
To investigate, the team studied 152,622 Holocaust survivors who were followed for more than 45 years. Two separate definitions of exposure were used. One definition was based on the individual's entitlement for compensation according to a set of laws. The other was based on the country of origin, using a classification of countries during the war into those that were directly governed by Nazi Germany and other non-occupied countries.
Cancer was diagnosed in 22 percent of those who were granted compensation for suffering persecution during the war versus 16 percent of those who were denied compensation. Survivors who were granted compensation had a six percent higher risk of developing any type of cancer than those who were denied compensation, and they had a 12 percent increased risk for colorectal cancer and a 37 percent increased risk for lung cancer. Those born in occupied countries had an eight percent increased risk of developing any cancer than those born in non-occupied countries, as well as eight percent and 12 percent increased risks of colorectal cancer and lung cancer, respectively. The investigators observed no elevated risks for breast cancer and gynecologic cancers among female survivors.
"The data emphasize the importance of learning about the combined effect of several exposures occurring intensely and contemporaneously on cancer risk, such as those that unfortunately occurred during World War II," said Prof. Sadetzki. "Such inspection cannot be conducted by experimental studies and could only be evaluated by using observational epidemiological surveys."
An accompanying editorial notes that the associations reported by Prof. Sadetzki and colleagues between the extreme deprivation experienced by Holocaust survivors and cancer may also have parallels with other extreme population-level events, including in racial/ethnic minority groups who experience severe social deprivation over time.
###
Additional Information
Full Citations
"Cancer Risk Among Holocaust Survivors in Israel--A Nationwide Study." Siegal Sadetzki, Angela Chetrit, Laurence S. Freedman, Nina Hakak, Micha Barchana, Raphael Catane, and Mordechai Shani. CANCER; Published Online: July 10, 2017 (DOI: 10.1002/cncr.30783).
URL Upon Publication: http://doi.wiley.com/10.1002/cncr.30783
"Extreme Population-Level Events: Do They Have an Impact on Cancer?" Beti Thompson, Sarah Gehlert, and Electra D. Paskett. CANCER; Published Online: July 10, 2017 (DOI: 10.1002/cncr.30778).
URL Upon Publication: http://doi.wiley.com/10.1002/cncr.30778
Author Contact: Lee Gat, of the Sheba Medical Center, at Lee.gat@sheba.health.gov.il or 03- 530 3296.
About the Journal
CANCER is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of CANCER is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology, course, and treatment of human cancer. CANCER is published on behalf of the American Cancer Society by Wiley and can be accessed online at http://wileyonlinelibrary.com/journal/cancer.
Follow us on Twitter @JournalCancer and Facebook https://www.facebook.com/ACSJournals
About Wiley
Wiley, a global company, helps people and organizations develop the skills and knowledge they need to succeed. Our online scientific, technical, medical, and scholarly journals, combined with our digital learning, assessment and certification solutions help universities, learned societies, businesses, governments and individuals increase the academic and professional impact of their work. For more than 200 years, we have delivered consistent performance to our stakeholders. The company's website can be accessed at http://www.wiley.com.
Journal
Cancer